---
figid: PMC6180304__EMMM-10-e8259-g002
figlink: /pmc/articles/PMC6180304/figure/emmm201708259-fig-0002/
number: F2
caption: (1) The purines ATP and adenosine ligate to their receptors P2X7 and A2AR,
  respectively, which act through PKA/PKC signaling and thereby activate IKK. IKK
  aids to cleave and translocate NF‐κB into the nucleus and induce inflammatory gene
  expression and cytokine release. A2AR additionally potentiates the expression of
  the complement component C3 and the opsonin C1q. Neuroprotective effects were observed
  when A2AR and P2X7R were blocked using the selective inhibitors SCH58261 and A438079,
  respectively. (2) Intravitreal administration of polySia avDP20 compensates for
  desialylated neurons by binding to its receptor SIGLEC‐11 and inhibiting neurotoxic
  inflammation through its ITIM domain. During inflammation, desialylated neurons
  activate CR3 associated ITAM and thereby trigger excessive release of ROS via NOX2.
  (3) The IFN‐β pathway involves STAT1‐ and STAT2‐induced SOCS1/SOCS3 release which
  reduces cytokine expression through a negative feedback and inhibits IL‐6 signaling.
  (4) Neutralizing antibodies such as infliximab aid to neutralize cytosolic TNF‐α.
  (5) TSPO ligands such as XBD173 stimulate the production of neurosteroids which
  limit the release of pro‐inflammatory cytokines. (6) Minocycline is a potent inhibitor
  of NF‐κB signaling.
pmcid: PMC6180304
papertitle: Modulation of three key innate immune pathways for the most common retinal
  degenerative diseases.
reftext: Isha Akhtar‐Schäfer, et al. EMBO Mol Med. 2018 Oct;10(10):e8259.
pmc_ranked_result_index: '138745'
pathway_score: 0.9632371
filename: EMMM-10-e8259-g002.jpg
figtitle: Three key innate immune pathways for the most common retinal degenerative
  diseases
year: '2018'
organisms: Homo sapiens
ndex: e60e1a12-ded7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6180304__EMMM-10-e8259-g002.html
  '@type': Dataset
  description: (1) The purines ATP and adenosine ligate to their receptors P2X7 and
    A2AR, respectively, which act through PKA/PKC signaling and thereby activate IKK.
    IKK aids to cleave and translocate NF‐κB into the nucleus and induce inflammatory
    gene expression and cytokine release. A2AR additionally potentiates the expression
    of the complement component C3 and the opsonin C1q. Neuroprotective effects were
    observed when A2AR and P2X7R were blocked using the selective inhibitors SCH58261
    and A438079, respectively. (2) Intravitreal administration of polySia avDP20 compensates
    for desialylated neurons by binding to its receptor SIGLEC‐11 and inhibiting neurotoxic
    inflammation through its ITIM domain. During inflammation, desialylated neurons
    activate CR3 associated ITAM and thereby trigger excessive release of ROS via
    NOX2. (3) The IFN‐β pathway involves STAT1‐ and STAT2‐induced SOCS1/SOCS3 release
    which reduces cytokine expression through a negative feedback and inhibits IL‐6
    signaling. (4) Neutralizing antibodies such as infliximab aid to neutralize cytosolic
    TNF‐α. (5) TSPO ligands such as XBD173 stimulate the production of neurosteroids
    which limit the release of pro‐inflammatory cytokines. (6) Minocycline is a potent
    inhibitor of NF‐κB signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKCB
  - PRKCD
  - MFAP1
  - C1QA
  - C1QB
  - JAK1
  - IL6
  - IL6R
  - IKBKB
  - PRKCE
  - PRKCG
  - GNAL
  - PRKCA
  - IKBKG
  - PRKAR2B
  - IRF9
  - GNAS
  - SOCS3
  - STAT1
  - PRKD3
  - CHUK
  - PRKAR1B
  - PRKAR2A
  - STAT2
  - SIGLEC11
  - SOCS1
  - IFNAR1
  - WDTC1
  - NFKB1
  - NFKB2
  - PRKACA
  - PRKACB
  - NFKBIA
  - CYBB
  - PTPN6
  - TNF
  - PRKACG
  - PRKAR1A
  - RELB
  - PRKCH
  - IFNAR2
  - IFNB1
  - PRKCZ
  - RELA
  - PRKCI
  - PRKCQ
  - TYK2
  - TSPO
  - REL
  - A438079
  - ATP
  - ADP
  - AMP
  - Cholesterol
  - Minocycline
  - TAM
  - Cancer
genes:
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: C1q
  symbol: C1q
  source: bioentities_symbol
  hgnc_symbol: C1QA
  entrez: '712'
- word: C1q
  symbol: C1q
  source: bioentities_symbol
  hgnc_symbol: C1QB
  entrez: '713'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: IL-6
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: Gs
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: IRF9
  symbol: IRF9
  source: hgnc_symbol
  hgnc_symbol: IRF9
  entrez: '10379'
- word: Gs
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: socs3
  symbol: SOCS3
  source: hgnc_symbol
  hgnc_symbol: SOCS3
  entrez: '9021'
- word: STAT1
  symbol: STAT1
  source: hgnc_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: STAT2
  symbol: STAT2
  source: hgnc_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: SIGLEC-11
  symbol: SIGLEC11
  source: hgnc_symbol
  hgnc_symbol: SIGLEC11
  entrez: '114132'
- word: SoCS1
  symbol: SOCS1
  source: hgnc_symbol
  hgnc_symbol: SOCS1
  entrez: '8651'
- word: IFNAR1
  symbol: IFNAR1
  source: hgnc_symbol
  hgnc_symbol: IFNAR1
  entrez: '3454'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: NOX2
  symbol: NOX2
  source: hgnc_alias_symbol
  hgnc_symbol: CYBB
  entrez: '1536'
- word: SHP1
  symbol: SHP-1
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN6
  entrez: '5777'
- word: TNFa
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: IFNAR2
  symbol: IFNAR2
  source: hgnc_symbol
  hgnc_symbol: IFNAR2
  entrez: '3455'
- word: IFN-B
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: TYK2
  symbol: TYK2
  source: hgnc_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: TSPO
  symbol: TSPO
  source: hgnc_symbol
  hgnc_symbol: TSPO
  entrez: '706'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
chemicals:
- word: A438079
  source: MESH
  identifier: C523668
- word: ATP
  source: MESH
  identifier: D000255
- word: ADP
  source: MESH
  identifier: D000244
- word: AMP
  source: MESH
  identifier: D000249
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: Minocycline
  source: MESH
  identifier: D008911
- word: TAM
  source: MESH
  identifier: C419191
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC6180304__F2
redirect_from: /figures/PMC6180304__F2
figtype: Figure
---
